More recent publications by other groups also reported that miR-152 targets SOCS3 to inhibit hepatic insulin resistance in mice with gestational diabetes and that miR-148 silencing in MIN-6 β-cells and mouse islets downregulates insulin promoter activity and expression (50, 51). This evidence concerns the gene INS and Insulin resistance.